St. James Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$884K Sell
7,917
-488
-6% -$49.9K 1.62% 25
2022
Q3
$730K Sell
8,405
-1,250
-13% -$112K 1.59% 28
2022
Q2
$887K Sell
9,655
-32,270
-77% -$2.86M 1.79% 25
2022
Q1
$3.44M Buy
+41,925
New +$3.31M 2.76% 19

Other funds holding MRK

St. James Investment Advisors's MRK Position: Q4 2022 in Review

St. James Investment Advisors reduced its Merck (MRK) stake by 5.8% in Q4 2022, selling an estimated $49.9K and leaving 7,917 shares worth $884K. The position accounts for 1.62% of the portfolio, ranked #25.

St. James Investment Advisors first reported a position in MRK in Q1 2022 and has held it in 4 quarters since. The position peaked at $3.44M in Q1 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • St. James Investment Advisors held 7,917 shares of Merck worth $884K as of Q4 2022.
  • St. James Investment Advisors sold 488 Merck shares in Q4 2022, an estimated $49.9K.
  • Merck made up 1.62% of St. James Investment Advisors's portfolio in Q4 2022, its #25 holding.
  • St. James Investment Advisors first reported a position in Merck in Q1 2022 and has held it in 4 quarters since.
  • St. James Investment Advisors's Merck position peaked at $3.44M in Q1 2022.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on St. James Investment Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.